"Antibody Formation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
Descriptor ID |
D000917
|
MeSH Number(s) |
G12.070
|
Concept/Terms |
Antibody Formation- Antibody Formation
- Formation, Antibody
- Antibody Response
- Antibody Responses
- Response, Antibody
- Responses, Antibody
- Antibody Production
- Production, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Formation".
Below are MeSH descriptors whose meaning is more specific than "Antibody Formation".
This graph shows the total number of publications written about "Antibody Formation" by people in this website by year, and whether "Antibody Formation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 0 | 3 | 3 |
2005 | 0 | 4 | 4 |
2006 | 1 | 8 | 9 |
2007 | 2 | 0 | 2 |
2008 | 1 | 2 | 3 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 2 | 3 |
2013 | 2 | 1 | 3 |
2014 | 1 | 1 | 2 |
2015 | 1 | 1 | 2 |
2016 | 0 | 3 | 3 |
2017 | 17 | 34 | 51 |
2018 | 20 | 37 | 57 |
2019 | 10 | 13 | 23 |
2020 | 18 | 37 | 55 |
2021 | 39 | 79 | 118 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibody Formation" by people in Profiles.
-
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination. Clin Chem. 2021 12 30; 68(1):251-253.
-
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281.
-
Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
-
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
-
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV. AIDS. 2021 11 15; 35(14):2399-2401.
-
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease. JAMA Oncol. 2021 11 01; 7(11):1714-1716.
-
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273. JAMA. 2021 Oct 19; 326(15):1533-1535.
-
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection. J Infect Dis. 2021 09 17; 224(6):1097-1099.
-
Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856.
-
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant. 2021 12; 21(12):4043-4051.